Alcuni articoli che trattano aspetti endocrinologici della Sindrome da Insensibilità agli Androgeni e delle altre Differenze dello Sviluppo del Sesso (DSD), in particolare per quanto riguarda il rischio tumorale, l’asportazione delle gonadi (gonadectomia), la terapia ormonale sostitutiva e gli effetti sulla mineralizzazione ossea (rischio di osteoporosi).
S. F. Ahmed, J. C. Achermann, W. Arlt, A. H. Balen, G. Conway, Z. L. Edwards, S. Elford, I. A. Hughes, L. Izatt, N. Krone, H. L. Miles, S. O’Toole, L. Perry, C. Sanders, M. Simmonds, A. M. Wallace, A. Watt & D. Willis
UK guidance on the initial evaluation of an infant or an adolescent with suspected Disorder of Sex Development.
Clinical Endocrinology, 2011
Testo in inglese | Introduzione in italiano
S. Bertelloni
Gonadal surgery in Complete Androgen Insensitivity Syndrome: a debate
Sexual Development, 2017
S. Bertelloni, M. C. Meriggiola, E. Dati, A. Balsamo & G. I. Baroncelli
Bone mineral density in women living with Complete Androgen Insensitivity Syndrome and intact testes or removed gonads
Sexual Development, 2017
S. Bertelloni, E. Dati, G. I. Baroncelli & O. Hiort
Hormonal management of Complete Androgen Insensitivity Syndrome from adolescence onward
Horm Res Paediatr, 2011
Disordini dello Sviluppo Sessuale: terapia ormonale in adolescenza
Sintesi a cura degli autori da:
S. Bertelloni, E. Dati & G. I. Baroncelli
“Disorders of Sex Development: Hormonal Management in Adolescence”
Gynecol Endocrinol, 2008
W. Birnbaum & S. Bertelloni
Sex hormone replacement in Disorders of Sex Development
Endocr Dev, 2014
Testo in inglese | Riassunto in italiano
W. Birnbaum, L. Marshall, R. Werner, A. Kulle, A. Lux, S. Kropf, O. Hiort
Oestrogen versus androgen in hormone-replacement therapy for Complete Androgen Insensitivity Syndrome: a multicentre, randomised, double-dummy, double-blind crossover trial
The Lancet: Diabetes & Endocrinology, 2018
S. Connor
From Minnie to Mickey (and all they did was turn off a gene)
The Independent, 2009
M. Cools & L. H. J. Looijenga
Update on the pathophysiology and risk factors for the development of malignant testicular germ cell tumors in Complete Androgen Insensitivity Syndrome
Sexual Development, 2017
Rischio di neoplasia gonadica nelle persone con Disordini della Differenziazione Sessuale
Riduzione cura del dott. Silvano Bertelloni, da:
M. Cools, S. L. S. Drop, K. P. Wolffenbuttel, J. W. Oosterhuis & L. H. J. Looijenga
“Germ cell tumors in the intersex gonad: old Paths, new directions, moving frontiers”
Endocr Reviews, 2006
E. Dati, S. Bertelloni, G.I. Baroncelli, F. Baldinotti, A. Fogli, X. Erba & P. Simi
Bone mineral density in young women with Complete Androgen Insensitivity Syndrome.
The AISIA study: preliminary data
U. Döhnert, L. Wünsch & O. Hiort
Gonadectomy in Complete Androgen Insensitivity Syndrome: why and when?
Sexual Development, 2017
U. Döhnert, S. Bertelloni, R. Werner, E. Dati & O. Hiort
Characteristic features of reproductive hormone profiles in late adolescent and adult females with Complete Androgen Insensitivity Syndrome
Sexual Development, 2015
G. Gava, I. Mancini, I. Orsili, S. Bertelloni, S. Alvisi, R. Seracchioli & M. C. Meriggiola
Bone mineral density, body composition and metabolic profiles in adult women with complete androgen insensitivity syndrome and removed gonads using oral or transdermal estrogens
European Journal of Endocrinology, 2019
S. E. Hannema, I. S. Scott, E. Rajpert-De Meyts, N. E. Skakkebæk, N. Coleman & I. A. Hughes
Testicular development in the Complete Androgen Insensitivity Syndrome
Journal of Pathology, 2006
M. Jürgensen, O. Hiort, P. M. Holterhus & U. Thyen
Gender role behavior in children with XY karyotype and Disorders of Sex Development
Hormones and Behavior, 2007
Testo in inglese | Abstract in italiano
T. F. J. King, W. Z. M. Wat, S. M. Creighton & G. S. Conway
Bone mineral density in complete androgen insensitivity syndrome and the timing of gonadectomy
Clinical Endocrinology, 2017
B. B. Mendonca, S. Domenice, I. J. Arnhold & E. M. Costa
Disordini dello Sviluppo Sessuale 46XY
Clinical Endocrinology, 2008
Testo in inglese | Riassunto in italiano
J. Pleskacova, R. Hersmus, J. W. Oosterhuis, B. A. Setyawati, S. M. Faradz, M. Cools, K. P. Wolffenbuttel, J. Lebl, S. L. Drop & L. H. Looijenga
Tumor risk in Disorders of Sex Development
Sexual Development, 2010
Testo in inglese | Riassunto in italiano
Mineralizzazione ossea nei Disordini della Differenziazione Sessuale: le donne con sindrome da insensibilità agli androgeni sono a rischio di osteoporosi
Riduzione a cura del dott. Silvano Bertelloni, da:
– V. Sobel, B. Schwartz, Y. Zhu, J. J. Cordero & J. Imperato-McGinley
“Bone mineral density in the Complete Androgen Insensitivity and 5a-Reductase-2 Deficiency Syndromes”
J Clin Endocrinol Metab, 2006
– D. L. S. Danilovic, P. H. S. Correa, E. M. F. Costa, K. F. S. Melo, B. B. Mendonca & I. J. P. Arnhold
“Height and bone mineral density in androgen insensitivity syndrome with mutations in the androgen receptor gene” Osteoporos Int, 2007